置入胰管支架对ERCP取石联合ERBD术后肝外胆管结石复发的影响因素分析OA
Analysis of influencing factors of placement of pancreatic duct stent on recurrence of extrahepatic bile duct stones after ERCP lithotomy combined with ERBD
目的:探讨胰管支架对内镜逆行胰胆管造影(ERCP)取石联合内镜逆行胆管引流(ERBD)术后肝外胆管结石远期复发的影响,为临床治疗与预防提供参考.方法:纳入2019年4月至2024年8月接受ERCP取石+ERBD治疗的366例肝外胆管结石病人,按是否接受ERPD分为研究组与对照组,随访并比较复发情况.采用倾向评分匹配法(PSM)消除混杂偏倚,通过Kaplan-Meier生存曲线及COX回归分析影响因素.结果:共366例病人中位随访13.8(6.2,29.8)个月,复发13例(3.6%).PSM后Kaplan-Meier生存曲线显示,研究组复发风险显著降低(HR=0.092,95%CI:0.012~0.716,P=0.004).COX回归分析显示,十二指肠乳头长度>8 mm(HR=4.04,95%CI:1.13~14.45,P=0.032)、结石类型(HR=0.10,95%CI:0.01~0.85,P=0.035)和ERPD(HR=0.04,95%CI:0.00~0.72,P=0.029)为独立影响因素.结论:ERPD是ERCP取石并ERBD术后肝外胆管结石远期复发的独立保护因素,十二指肠乳头长度>8 mm为危险因素,块状肝外胆管结石较泥沙样结石复发风险低.
Objective To investigate the impact of pancreatic duct stent on long-term recurrence of extrahepatic bile duct stones after endoscopic retrograde cholangiopancreatography(ERCP)lithotomy combined with endoscopic retrograde biliary drainage(ERBD),and to provide clinical reference for treating patients with extrahepatic bile duct stones and preventing stone recurrence.Methods A total of 366 patients with extrahepatic bile duct stones treated by ERCP lithotomy and ERBD between April 2019 and August 2024 were enrolled and followed up.The patients were divided into a research group and a control group according to whether received ERPD.Recurrence outcomes were collected and compared between the two groups.Propensity score matching(PSM)was used to eliminate confounding bias,followed by Kaplan-Meier survival curve generation.COX regression analysis was performed to analyze the influencing factors.Results A total of 366 patients were included,with a median follow-up duration of 13.8(6.2,29.8)months.Thirteen cases(3.6%)developed recurrence.After PSM,the Kaplan-Meier survival curve showed the recurrence risk of the research group was significantly reduced(HR=0.092,95%CI:0.012-0.716,P=0.004).COX regression analysis revealed that duodenal papilla length>8 mm(HR=4.04,95%CI:1.13-14.45,P=0.032),stone type(HR=0.10,95%CI:0.01-0.85,P=0.035),and ERPD(HR=0.04,95%CI:0.00-0.72,P=0.029)were independent influencing factors.Conclusions ERPD is an independent protective factor against long-term recurrence of extrahepatic bile duct stones after ERCP lithotomy and ERBD.A duodenal papilla length>8 mm is an independent risk factor.Block extrahepatic bile duct stones have a lower long-term recurrence risk than silt-like stones.
王玉彬;张红雷;张诚;孔祥余;项羽凯;杨玉龙
同济大学医学院,上海 200331同济大学附属东方医院胆石病中心,上海 200120同济大学附属东方医院胆石病中心,上海 200120同济大学附属东方医院胆石病中心,上海 200120同济大学附属东方医院胆石病中心,上海 200120同济大学医学院,上海 200331
医药卫生
肝外胆管结石内镜逆行胰胆管造影胰管支架胆管支架结石复发
Extrahepatic bile duct stoneEndoscopic retrograde cholangiopancreatograph(ERCP)Pancreatic duct stentBiliary stentStone recurrence
《外科理论与实践》 2026 (4)
326-334,9
评论